{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:16:39Z","timestamp":1772111799041,"version":"3.50.1"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"1013","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Neuromyelitis optica (NMO) is a relapsing inflammatory disorder of the central nervous system that closely resembles multiple sclerosis. This review discusses recent understanding of NMO with reference to epidemiology, clinical spectrum, immunopathology, diagnostic evaluation, clinical course and management. Within the clinical spectrum of NMO, the classical form (with relapsing opticomyelitis) and limited forms (either recurrent myelitis or optic neuritis), as well as its association with other autoimmune disorders, have been recognised in recent years. Further, symptomatic or asymptomatic cerebral lesions may be present, and such brain lesions do not necessarily exclude the diagnosis. In the appropriate clinical context, the diagnosis is supported by longitudinally extensive myelitis on spinal MRI. Overwhelming evidence strongly indicates that aquaporin 4 antibody has a pathogenetic role in the development of NMO and serves as a useful diagnostic and prognostic marker. Detection of this autoantibody has led to the categorisation of NMO as an autoimmune channelopathy. NMO can be distinguished from multiple sclerosis by a combination of clinical, radiological and laboratory studies. However, the nosological position of Asian opticospinal multiple sclerosis is not settled. In NMO, acute attacks usually result in moderate to severe functional impairment, and, in the absence of a secondary progressive course (unlike relapsing\u2013remitting multiple sclerosis), prevention of relapses is of crucial importance in the management of the disease. Indeed, relapse prevention with long-term immunosuppressive medication remains the cornerstone of therapy in this otherwise debilitating disease!<\/jats:p>","DOI":"10.1136\/pgmj.2009.091389","type":"journal-article","created":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T12:33:13Z","timestamp":1268829193000},"page":"153-159","source":"Crossref","is-referenced-by-count":24,"title":["Neuromyelitis optica: an overview"],"prefix":"10.1093","volume":"86","author":[{"given":"R","family":"Nandhagopal","sequence":"first","affiliation":[{"name":"Neurology Unit, Department of Medicine, College of Medicine & Health Sciences, Sultan Qaboos University Hospital , Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Al-Asmi","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Medicine, College of Medicine & Health Sciences, Sultan Qaboos University Hospital , Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunodaya R","family":"Gujjar","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Medicine, College of Medicine & Health Sciences, Sultan Qaboos University Hospital , Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,3,17]]},"reference":[{"key":"2023041908481425100_b1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"2023041908481425100_b2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"2023041908481425100_b3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archneur.61.9.1401","article-title":"The natural history of recurrent optic neuritis","volume":"61","author":"Pirko","year":"2004","journal-title":"Arch Neurol"},{"key":"2023041908481425100_b4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2006.06.060","article-title":"Natural history of the visual impairment of relapsing neuromyelitis optica","volume":"114","author":"Merle","year":"2007","journal-title":"Ophthalmology"},{"key":"2023041908481425100_b5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.56.4.507","article-title":"MS and neuromyelitis optica in Martinique (French West Indies)","volume":"56","author":"Cabre","year":"2001","journal-title":"Neurology"},{"key":"2023041908481425100_b6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-Gomez","year":"2009","journal-title":"J Neurol"},{"key":"2023041908481425100_b7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","article-title":"Multiple sclerosis in the Japanese population","volume":"2","author":"Kira","year":"2003","journal-title":"Lancet Neurol"},{"key":"2023041908481425100_b8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1474-4422(06)70333-7","article-title":"OSMS is NMO, but not MS: proven clinically and pathologically","volume":"5","author":"Weinshenker","year":"2006","journal-title":"Lancet Neurol"},{"key":"2023041908481425100_b9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1196\/annals.1444.002","article-title":"Neuromyelitis optica and asian phenotype of multiple sclerosis","volume":"1142","author":"Kira","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"2023041908481425100_b10","first-page":"175","article-title":"Devic\u2019s neuromyelitis optica: a clinicopathological review of the literature in connection with a case showing fatal dysautonomia","volume":"17","author":"Baudoin","year":"1998","journal-title":"Clin Neuropathol"},{"key":"2023041908481425100_b11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"2023041908481425100_b12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0404.2008.01012.x","article-title":"Brain magnetic resonance imaging abnormalities in neuromyelitis optica","volume":"118","author":"Li","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"2023041908481425100_b13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/1352458507082617","article-title":"Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders","volume":"14","author":"Cabrera-Gomez","year":"2008","journal-title":"Mult Scler"},{"key":"2023041908481425100_b14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1352458506070725","article-title":"Brain magnetic resonance imaging findings in relapsing neuromyelitis optica","volume":"13","author":"Cabrera-Gomez","year":"2007","journal-title":"Mult Scler"},{"key":"2023041908481425100_b15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","article-title":"CNS aquaporin-4 autoimmunity in children","volume":"71","author":"McKeon","year":"2008","journal-title":"Neurology"},{"key":"2023041908481425100_b16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneurol.2007.16","article-title":"Cognitive functions in neuromyelitis optica","volume":"65","author":"Blanc","year":"2008","journal-title":"Arch Neurol"},{"key":"2023041908481425100_b17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/jnnp.2008.145391","article-title":"Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations","volume":"79","author":"Takahashi","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023041908481425100_b18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/01.wnl.0000183151.19351.82","article-title":"Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica","volume":"65","author":"Misu","year":"2005","journal-title":"Neurology"},{"key":"2023041908481425100_b19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00415-009-0139-4","article-title":"Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody","volume":"256","author":"Baba","year":"2009","journal-title":"J Neurol"},{"key":"2023041908481425100_b20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1191\/1352458505ms1200cr","article-title":"Neuromyelitis optica with hypothalamic involvement","volume":"11","author":"Poppe","year":"2005","journal-title":"Mult Scler"},{"key":"2023041908481425100_b21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","article-title":"Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders","volume":"72","author":"Magana","year":"2009","journal-title":"Neurology"},{"key":"2023041908481425100_b22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jnnp.2008.157693","article-title":"Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica","volume":"80","author":"Viegas","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023041908481425100_b23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00415-008-0545-z","article-title":"Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study","volume":"255","author":"Nakamura","year":"2008","journal-title":"J Neurol"},{"key":"2023041908481425100_b24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1179\/016164106X98279","article-title":"Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica?","volume":"28","author":"Okai","year":"2006","journal-title":"Neurol Res"},{"key":"2023041908481425100_b25","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/archneur.65.7.920","article-title":"Optical coherence tomography in neuromyelitis optica","volume":"65","author":"de Seze","year":"2008","journal-title":"Arch Neurol"},{"key":"2023041908481425100_b26","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1167\/iovs.08-1815","article-title":"Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica","volume":"49","author":"Merle","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2023041908481425100_b27","first-page":"1009","article-title":"Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica","volume":"27","author":"Yu","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"2023041908481425100_b28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1212\/01.WNL.0000106946.08741.41","article-title":"Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica","volume":"62","author":"Rocca","year":"2004","journal-title":"Neurology"},{"key":"2023041908481425100_b29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1148\/radiol.2461062075","article-title":"Pathogenesis of normal-appearing white matter damage in neuromyelitis optica: diffusion-tensor MR imaging","volume":"246","author":"Yu","year":"2008","journal-title":"Radiology"},{"key":"2023041908481425100_b30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1191\/1352458504ms988oa","article-title":"Oligoclonal bands in Devic\u2019s neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations","volume":"10","author":"Bergamaschi","year":"2004","journal-title":"Mult Scler"},{"key":"2023041908481425100_b31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1191\/1352458503ms947oa","article-title":"Is Devic\u2019s neuromyelitis optica a separate disease? A comparative study with multiple sclerosis","volume":"9","author":"de Seze","year":"2003","journal-title":"Mult Scler"},{"issue":"Suppl 4","key":"2023041908481425100_b32","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1007\/s10072-004-0343-z","article-title":"Cerebrospinal fluid findings in Devic\u2019s neuromyelitis optica","volume":"25","author":"Zaffaroni","year":"2004","journal-title":"Neurol Sci"},{"key":"2023041908481425100_b33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","article-title":"Marked increase in cerebrospinal fluid glial fibrillary acidic protein in neuromyelitis optica: an astrocytic damage marker","volume":"80","author":"Misu","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023041908481425100_b34","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.wnl.0000256820.26489.17","article-title":"High CSF neurofilament heavy chain levels in neuromyelitis optica","volume":"68","author":"Miyazawa","year":"2007","journal-title":"Neurology"},{"issue":"Pt 3","key":"2023041908481425100_b35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/brain\/124.3.493","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic\u2019s neuromyelitis optica","volume":"124","author":"Mandler","year":"2001","journal-title":"Brain"},{"key":"2023041908481425100_b36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"2023041908481425100_b37","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"2023041908481425100_b38","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"2023041908481425100_b39","first-page":"99","article-title":"Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays","volume":"15","author":"Waters","year":"2008","journal-title":"Int MS J"},{"issue":"Pt 5","key":"2023041908481425100_b40","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"2023041908481425100_b41","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","article-title":"Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica","volume":"4","author":"Paul","year":"2007","journal-title":"PLoS Med"},{"key":"2023041908481425100_b42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2008.03.009","article-title":"Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay","volume":"196","author":"Hayakawa","year":"2008","journal-title":"J Neuroimmunol"},{"key":"2023041908481425100_b43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jneuroim.2009.10.002","article-title":"Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica","volume":"217","author":"Marnetto","year":"2009","journal-title":"J Neuroimmunol"},{"key":"2023041908481425100_b44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"issue":"Pt 11","key":"2023041908481425100_b45","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"2023041908481425100_b46","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1352458508092811","article-title":"Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica","volume":"14","author":"Weinstock-Guttman","year":"2008","journal-title":"Mult Scler"},{"issue":"Pt 7","key":"2023041908481425100_b47","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"issue":"Pt 5","key":"2023041908481425100_b48","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"issue":"Pt 5","key":"2023041908481425100_b49","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"2023041908481425100_b50","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: Passive transfer to rats by human immunoglobulin","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"2023041908481425100_b51","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J Immunol"},{"key":"2023041908481425100_b52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1352458508102085","article-title":"Is neuromyelitis optica associated with human leukocyte antigen?","volume":"15","author":"Zephir","year":"2009","journal-title":"Mult Scler"},{"key":"2023041908481425100_b53","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","article-title":"Neuromyelitis optica: clinical predictors of a relapsing course and survival","volume":"60","author":"Wingerchuk","year":"2003","journal-title":"Neurology"},{"key":"2023041908481425100_b54","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/01.wnl.0000254502.87233.9a","article-title":"A secondary progressive clinical course is uncommon in neuromyelitis optica","volume":"68","author":"Wingerchuk","year":"2007","journal-title":"Neurology"},{"key":"2023041908481425100_b55","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann Neurol"},{"key":"2023041908481425100_b56","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis","volume":"70","author":"Matiello","year":"2008","journal-title":"Neurology"},{"key":"2023041908481425100_b57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10072-007-0823-z","article-title":"Variable responses to rituximab treatment in neuromyelitis optica (Devic\u2019s disease)","volume":"28","author":"Capobianco","year":"2007","journal-title":"Neurol Sci"},{"key":"2023041908481425100_b58","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"key":"2023041908481425100_b59","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","article-title":"Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients","volume":"65","author":"Jacob","year":"2008","journal-title":"Arch Neurol"},{"key":"2023041908481425100_b60","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","article-title":"Devic\u2019s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine","volume":"51","author":"Mandler","year":"1998","journal-title":"Neurology"},{"key":"2023041908481425100_b61","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1352458506070732","article-title":"Immunosuppressive therapy is more effective than interferon in neuromyelitis optica","volume":"13","author":"Papeix","year":"2007","journal-title":"Mult Scler"},{"key":"2023041908481425100_b62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1191\/0961203306lu2265cr","article-title":"Neuromyelitis optica (Devic\u2019s syndrome) as first manifestation of systemic lupus erythematosus","volume":"15","author":"Jacobi","year":"2006","journal-title":"Lupus"},{"key":"2023041908481425100_b63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/rheumatology\/41.4.470","article-title":"Neuromyelitis optica (Devic\u2019s syndrome) in systemic lupus erythematosus: a case report","volume":"41","author":"Gibbs","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"2023041908481425100_b64","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/1352458508088941","article-title":"Minor salivary gland inflammation in Devic\u2019s disease and longitudinally extensive myelitis","volume":"14","author":"Javed","year":"2008","journal-title":"Mult Scler"},{"key":"2023041908481425100_b65","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/jnnp.2004.055491","article-title":"Gluten sensitivity and neuromyelitis optica: two case reports","volume":"76","author":"Jacob","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023041908481425100_b66","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2006.01392.x","article-title":"Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population","volume":"13","author":"Furukawa","year":"2006","journal-title":"Eur J Neurol"},{"key":"2023041908481425100_b67","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1352458507082355","article-title":"Neuromyelitis optica (Devic\u2019s disease) in a patient with syphilis","volume":"14","author":"Wilcox","year":"2008","journal-title":"Mult Scler"},{"key":"2023041908481425100_b68","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s10156-006-0475-6","article-title":"Post-dengue neuromyelitis optica: case report of a Japanese-descendent Brazilian child","volume":"12","author":"Miranda de Sousa","year":"2006","journal-title":"J Infect Chemother"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/86\/1013\/153\/50022375\/postgradmedj-86-153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/86\/1013\/153\/50022375\/postgradmedj-86-153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T09:12:38Z","timestamp":1681895558000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/86\/1013\/153\/7007536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,1]]},"references-count":68,"journal-issue":{"issue":"1013","published-online":{"date-parts":[[2010,3,17]]},"published-print":{"date-parts":[[2010,3,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2009.091389","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,3]]},"published":{"date-parts":[[2010,3,1]]}}}